Press releases – 2023

Whether it is new and groundbreaking research results, university topics or events – in our press releases you can find everything you need to know about the happenings at Goethe University. To subscribe, just send an email to ott@pvw.uni-frankfurt.de

Goethe University PR & Communication Department 

Theodor-W.-Adorno Platz 1
60323 Frankfurt 
presse@uni-frankfurt.de

 

Jan 9 2023
10:00

Particle analyses and laboratory experiments reveal how ultrafine particles form – Study by Goethe University Frankfurt in collaboration with the Hessian Agency for Nature Conservation, Environment and Geology

Jet engine lubrication oils are a major source of ultrafine particles

Measurements conducted by the Hessian Agency for Nature Conservation, Environment and Geology (HLNUG) in recent years have shown that Frankfurt International Airport is a major source of ultrafine particles and that these can disperse over long distances across the city. In collaboration with experts at the HLNUG, researchers at Goethe University Frankfurt have now discovered that the ultrafine particles partly consist of synthetic jet oils. The research team has deduced that emissions from lubrication oils must be lowered in addition to those from kerosene in order to reduce the concentration of ultrafine particles and thus improve air quality. 

FRANKFURT. Ultrafine particles form during combustion processes, for example when wood or biomass is burned, as well as in power and industrial plants. Alongside road traffic, large airports are a major source of these ultrafine particles, which are less than 100 millionths of a millimetre (100 nanometres) in size. Because they are so small, they can penetrate deep into the lower respiratory tract, overcome the air-blood barrier and, depending on their composition, cause inflammatory reactions in the tissue, for example. What's more, ultrafine particles are suspected of being capable of triggering cardiovascular diseases. 

Since several years, the Hessian Agency for Nature Conservation, Environment and Geology (HLNUG) has been measuring the number and size of ultrafine particles at various air monitoring stations in the vicinity of Frankfurt International Airport, for example in the Frankfurt suburb of Schwanheim and in Raunheim. Last year, scientists led by Professor Alexander Vogel at Goethe University Frankfurt analysed the chemical composition of the ultrafine particles and came across a group of organic compounds which, according to their chemical fingerprints, originated from aircraft lubrication oils. 

The research team has now corroborated this finding by means of further chemical measurements of the ultrafine particles: the particles originated to a significant degree from synthetic jet oils and were particularly prevalent in the smallest particle classes, i.e. particles 10 to 18 nanometres in size. Such lubrication oils can enter the exhaust plume of an aircraft's engines, for example through vents where nanometre-sized oil droplets and gaseous oil vapours are not fully retained. 

In laboratory experiments, the researchers also succeeded in reproducing the formation of ultrafine particles from lubrication oils. To this end, a common engine lubrication oil was first evaporated at around 300 °C in a hot gas stream, which simulated the exhaust plume of an aircraft engine, and subsequently cooled down. The number-size distribution of the freshly formed particles was then measured. 

Alexander Vogel, Professor for Atmospheric Environmental Analytics at the Institute for Atmospheric and Environmental Sciences of Goethe University Frankfurt, explains: “When the oil vapour cools down, the gaseous synthetic esters are supersaturated and form the nuclei for new particles that can then grow fast to around 10 nanometres in size. These particles, as our experiments indicate, constitute a large fraction of the ultrafine particles produced by aircraft engines. The previous assumption that ultrafine particles originate primarily from sulphur and aromatic compounds in kerosene is evidently incomplete. According to our findings, lowering lubrication oil emissions from jet engines holds significant potential for reducing ultrafine particles." 

The experiments show that the formation of ultrafine particles in jet engines is not confined to the combustion of kerosene alone. Potential mitigation measures should take this into consideration. This means that using low-sulphur kerosene or switching to sustainable aviation fuel cannot eliminate all the pollution caused by ultrafine particles. 

A comprehensive scientific study by the Federal State of Hesse, which will start in 2023, will examine pollution from ultrafine particles and their impact on health. In this context, the results from the current study can help to identify airport-specific particles and derive possible mitigation measures. 

Publication:
Florian Ungeheuer, Lucía Caudillo, Florian Ditas, Mario Simon, Dominik van Pinxteren, Dogushan Kilic, Diana Rose, Stefan Jacobi, Andreas Kürten, Joachim Curtius, Alexander L. Vogel: Nucleation of jet engine oil vapours is a large source of aviation-related ultrafine particles. Communications Earth & Environment (2022)
https://doi.org/10.1038/s43247-022-00653-w 

Picture download:
https://www.uni-frankfurt.de/130014225 

Caption: Lubrication oil in the hot exhaust plume of an aircraft engine can form ultrafine particles as soon as the plume cools down. This has now been corroborated in a study by Goethe University Frankfurt and the Hessian Agency for Nature Conservation, Environment and Geology. 

Photo: Alexander Vogel, Goethe University Frankfurt 

Further information:
Professor Alexander L. Vogel
Institute for Atmospheric and Environmental Sciences
Goethe University Frankfurt
Tel. +49 (0)69 798-40225
vogel@iau.uni-frankfurt.de
www.iau.uni-frankfurt.de
Twitter: @al_vogel, @HLNUG_Hessen


Editor: Dr. Markus Bernards, Science Editor, PR & Communication Office, Tel: +49 (0) 69 798-12498, Fax: +49 (0) 69 798-763 12531, bernards@em.uni-frankfurt.de

 

Jan 6 2023
10:02

Cell culture experiments by Goethe University Frankfurt and the University of Kent corroborate the effectiveness of tecovirimat, cidofovir and brincidofovir – the Frankfurt research group is funded by the Frankfurt Foundation for Children with Cancer

Monkeypox viruses remain sensitive to the available drugs

The three antiviral drugs commonly used to treat mpox viruses (monkeypox viruses) are also effective against the viruses from the current outbreak. This has been shown in cell culture experiments by scientists at Goethe University Frankfurt/University Hospital Frankfurt and the University of Kent in Canterbury, Great Britain. 

FRANKFURT/CANTERBURY. The mpox virus is closely related to the smallpox virus (variola virus), which caused large, deadly outbreaks before it was eradicated by vaccination at the end of the 1970s. While the smallpox virus led to very severe disease progression with a death rate of about 30 percent, mpox is milder. Nevertheless, the mortality rate is still about three percent. Particularly at risk of a severe course of the disease are people with a weakened immune system, elderly persons, pregnant women, newborn babies and young children. Until recently, mpox outbreaks only occurred in certain parts of Africa when humans became infected through contact with wild animals, typically rodents such as the Gambian pouched rat and the rope squirrel. 

However, in May 2022 a first large mpox outbreak outside Africa was detected; the virus spread solely through human-to-human transmission. This ongoing outbreak has so far reached more than 100 countries and been classified by the World Health Organisation (WHO) as a "Public Health Emergency of International Concern". 

About 10% of mpox patients require hospital treatment. Moreover, the current mpox outbreak differs from previous ones in terms of both disease transmission and symptoms. These differences raised concerns that the currently circulating mpox virus might have changed in such a way that it would no longer respond to the antiviral drugs available. 

Against this backdrop, an international research team led by Professor Jindrich Cinatl from the Institute of Medical Virology, Goethe University Frankfurt/University Hospital Frankfurt, and Professor Martin Michaelis from the School of Biosciences at the University of Kent have succeeded in isolating and cultivating viruses in cell culture from 12 patients from the current mpox outbreak. This has enabled them to test these mpox virus isolates in cultures of skin cells, which has been naturally infected by the mpox virus, for their sensitivity to three drugs presently available to treat the disease: tecovirimat, cidofovir and brincidofovir. 

The results showed that all 12 isolates continued to respond to treatment with clinically relevant concentrations of these commonly used drugs. 

Professor Jindrich Cinatl said: “We were really concerned that the virus could have changed and become resistant to the available therapies. It is good to see that this is not the case." 

Professor Martin Michaelis added: “These findings are very reassuring and give good cause to believe that the antiviral drugs already available will also be effective against the mpox virus in the current outbreak." 

The Frankfurt research group “Interdisciplinary Laboratory for Paediatric Tumour and Virus Research", led by Professor Jindrich Cinatl, is funded by the Frankfurt Foundation for Children with Cancer and hosted at the foundation's Dr. Petra Joh Research House. 

Publication: Denisa Bojkova, Marco Bechtel, Tamara Rothenburger, Katja Steinhorst, Nadja Zöller, Stefan Kippenberger, Julia Schneider, Victor M. Corman, Hannah Uri, Mark N. Wass, Gaby Knecht, Pavel Khaykin, Timo Wolf, Sandra Ciesek, Holger F. Rabenau, Martin Michaelis, Jindrich Cinatl jr. Drug sensitivity of currently circulating monkeypox viruses. New England Journal of Medicine (2022)
https://www.nejm.org/doi/full/10.1056/NEJMc2212136

Further information
Professor Jindrich
Cinatl Institute of Medical Virology
University Hospital Frankfurt/Goethe University Frankfurt
Tel.: +49 (0)69 6301-6409
cinatl@em.uni-frankfurt.de 

Professor Martin Michaelis
School of Biosciences
University of Kent
Tel.: +44 (0)1227 82-7804
Mobile: +44 (0)7561 333 094
m.michaelis@kent.ac.uk
Twitter:@MartMichaelis


Editor: Dr. Markus Bernards, Science Editor, PR & Communication Office, Tel: +49 (0) 69 798-12498, Fax: +49 (0) 69 798-763 12531, bernards@em.uni-frankfurt.de